EPISODE · May 11, 2021 · 21 MIN
Pat(i)ent Rights
from The Morning Brief · host The Economic Times
A waiver of intellectual property rights on Covid-19 vaccines and drugs alone may not benefit developing countries including India in the battle against the deadly disease. Murali Neelakantan, Former Global General Counsel of Cipla and Glenmark, and Vikas Dandekar, Editor, Pharma and Healthcare, ET Prime, explain what’s at stake for the patent holders and developing nations. The clip featuring Bill Gates used in the podcast belongs to Sky News.See omnystudio.com/listener for privacy information.
NOW PLAYING
Pat(i)ent Rights
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m